1. Home
  2. CLSD vs CSTE Comparison

CLSD vs CSTE Comparison

Compare CLSD & CSTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSD
  • CSTE
  • Stock Information
  • Founded
  • CLSD 2011
  • CSTE 1987
  • Country
  • CLSD United States
  • CSTE Israel
  • Employees
  • CLSD N/A
  • CSTE N/A
  • Industry
  • CLSD Biotechnology: Pharmaceutical Preparations
  • CSTE Building Materials
  • Sector
  • CLSD Health Care
  • CSTE Industrials
  • Exchange
  • CLSD Nasdaq
  • CSTE Nasdaq
  • Market Cap
  • CLSD 68.4M
  • CSTE 61.9M
  • IPO Year
  • CLSD 2016
  • CSTE 2012
  • Fundamental
  • Price
  • CLSD $0.42
  • CSTE $1.52
  • Analyst Decision
  • CLSD Hold
  • CSTE
  • Analyst Count
  • CLSD 4
  • CSTE 0
  • Target Price
  • CLSD $4.33
  • CSTE N/A
  • AVG Volume (30 Days)
  • CLSD 12.9M
  • CSTE 62.3K
  • Earning Date
  • CLSD 08-08-2025
  • CSTE 08-06-2025
  • Dividend Yield
  • CLSD N/A
  • CSTE N/A
  • EPS Growth
  • CLSD N/A
  • CSTE N/A
  • EPS
  • CLSD N/A
  • CSTE N/A
  • Revenue
  • CLSD $4,166,000.00
  • CSTE $406,178,000.00
  • Revenue This Year
  • CLSD $78.37
  • CSTE N/A
  • Revenue Next Year
  • CLSD $17.79
  • CSTE $6.60
  • P/E Ratio
  • CLSD N/A
  • CSTE N/A
  • Revenue Growth
  • CLSD N/A
  • CSTE N/A
  • 52 Week Low
  • CLSD $0.29
  • CSTE $1.52
  • 52 Week High
  • CLSD $1.65
  • CSTE $5.28
  • Technical
  • Relative Strength Index (RSI)
  • CLSD 39.95
  • CSTE 32.95
  • Support Level
  • CLSD $0.40
  • CSTE $1.52
  • Resistance Level
  • CLSD $0.47
  • CSTE $1.76
  • Average True Range (ATR)
  • CLSD 0.06
  • CSTE 0.14
  • MACD
  • CLSD 0.01
  • CSTE -0.02
  • Stochastic Oscillator
  • CLSD 26.87
  • CSTE 0.00

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

Share on Social Networks: